HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jill Tinmouth Selected Research

Guaiac

1/2021Morbidity and mortality after major large bowel resection of non-malignant polyp among participants in a population-based screening program.
10/2020Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation.
1/2017Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
1/2016Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.
9/2015The impact of stratifying by family history in colorectal cancer screening programs.
8/2015Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
7/2015Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.
3/2015Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jill Tinmouth Research Topics

Disease

17Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 06/2013
8Neoplasms (Cancer)
01/2022 - 03/2011
3Colonic Neoplasms (Colon Cancer)
01/2021 - 08/2004
3Diarrhea
11/2007 - 06/2006
2COVID-19
01/2022 - 10/2021
2Polyps
01/2021 - 11/2014
2Adenoma (Adenomas)
08/2015 - 11/2014
1Liver Failure
01/2022
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2022
1Hypersensitivity (Allergy)
10/2021
1Asthma (Bronchial Asthma)
10/2021
1Atypical Squamous Cells of the Cervix
01/2021
1Rectal Neoplasms (Rectal Cancer)
01/2021
1Aspiration Pneumonia
01/2018
1Anus Neoplasms (Anal Cancer)
09/2016
1Cholangitis
07/2014
1Breast Neoplasms (Breast Cancer)
06/2013
1Chronic Disease (Chronic Diseases)
06/2013
1Hepatomegaly
02/2012
1Fibrosis (Cirrhosis)
02/2012
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2011
1Metabolic Bone Diseases (Osteopenia)
06/2006
1Malnutrition (Nutritional Deficiencies)
06/2006
1Inflammation (Inflammations)
06/2002
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2002

Drug/Important Bio-Agent (IBA)

8GuaiacIBA
01/2021 - 03/2015
4Calcibiotic Root Canal SealerIBA
05/2018 - 11/2014
2CholesterolIBA
10/2015 - 06/2013
1CalciumIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
10/2015
1Imiquimod (Aldara)FDA LinkGeneric
08/2014
1amsonic acid (DAS)IBA
06/2013
1Alanine Transaminase (SGPT)IBA
02/2012
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2012
1Prothrombin (Factor II)IBA
02/2012
1CarcinogensIBA
10/2011
1Octreotide (Sandostatin)FDA LinkGeneric
05/2007
1LactaseIBA
06/2006
1LactoseFDA LinkGeneric
06/2006
1Coloring Agents (Dyes)IBA
06/2002

Therapy/Procedure

4Colectomy
01/2021 - 08/2004
3Highly Active Antiretroviral Therapy (HAART)
11/2007 - 06/2006
2Transplantation
01/2022 - 01/2002
2Therapeutics
09/2016 - 03/2011
2Stents
01/2016 - 08/2015
1Continuity of Patient Care
01/2022
1Liver Transplantation
01/2022
1Operative Surgical Procedures
01/2022
1Radiotherapy
01/2022
1Aftercare (After-Treatment)
10/2021
1Anesthesia
01/2018
1Cholecystectomy
07/2014